TSO3 to resubmit 510(k) for US regulatory clearance of STERIZONE 125L+ Sterilizer

NewsGuard 100/100 Score

TSO3 Inc. ("TSO3") (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that it has received instructions from US regulatory authorities to resubmit a 510(k) for its STERIZONE(R) 125L+ Sterilizer. As instructed by the Agency, TSO3 intends to provide additional data and to better establish the link between the sterilizer and a variety of accessory products used in the sterilizer, which are also subject to 510(k) clearance and have been previously submitted.

"TSO3 is eager to quickly provide additional data on the STERIZONE(R) 125L+ Sterilizer and to link the various accessory products together to support our superior claims", stated Mr. R.M. (Ric) Rumble, President and CEO of TSO3. "We estimate the time to complete the collection of data and modify the submission document will be approximately four weeks, which is about the same amount of time that it takes companies to respond to questions from the Agency during the review process. We remain absolutely confident in our ability to gain US regulatory clearance for this product, however, as it has always been the case, we are unable to accurately predict the timing of such clearance", Mr. Rumble concluded.

Source:

TSO3 INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shines light on the well-being challenges faced by women in healthcare